SCHEMBL31715308

SCHEMBL31715308

CC=C1CCCN1C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CTSK P43235 1/20 0.38
▸ HPGD P15428 1/20 0.36
▸ UCHL1 P09936 2/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ EPHX1 P07099 1/20 0.35
▸ NR1H2 P55055 1/20 0.35
▸ KDM1A O60341 1/20 0.35
▸ MPO P05164 1/20 0.34
▸ PREP P48147 1/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ USP30 Q70CQ3 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12350366 0.84 CTSK (0.38) USP2SMN1; SMN2CTSKHPGDMEN1
SCHEMBL30002394 0.82 HPGD (0.37) USP2SMN1; SMN2CTSKHPGDMEN1
SCHEMBL463899 0.82 CTSK (0.36) USP2SMN1; SMN2CTSKHPGDMEN1
SCHEMBL463898 0.82 CTSK (0.36) USP2SMN1; SMN2CTSKHPGDMEN1
SCHEMBL21348242 0.80 USP2 (0.34) USP2SMN1; SMN2CTSKHPGDUCHL1
SCHEMBL31322461 0.80 CTSK (0.40) USP2SMN1; SMN2CTSKHPGDMEN1
SCHEMBL1550544 0.79 USP2 (0.41) USP2SMN1; SMN2CTSKHPGDUCHL1
SCHEMBL15188491 0.79 CTSK (0.44) USP2SMN1; SMN2CTSKHPGDUCHL1
SCHEMBL205421 0.79 LMNA (0.48) USP2SMN1; SMN2CTSKHPGDMEN1
SCHEMBL31357623 0.79 HDAC1 (0.36) USP2SMN1; SMN2CTSKHPGDUCHL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025184391-A9 COVALENT INHIBITORS AND USES THEREOF ARRAKIS THERAPEUTICS, INC. (US) 2025-10-30 — — WO disclosed
Send feedback